Coronavirus: COVID-19 risks increased in people with diabetes

Coronavirus: COVID-19 risks increased in people with diabetes

We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

People with diabetes need better protection from COVID-19

When people are affected by endocrine disorders and diabetes mellitus, special attention should be given to them when treating COVID-19. According to current knowledge, people affected seem to be more likely to get COVID-19 and die more often from the consequences of the infection.

The latest study by the University of Leeds found that people with endocrine disorders and diabetes mellitus are more likely to develop COVID-19 and die more often from the infection. The results of the study were published in the English-language journal "Journal of Clinical Endocrinology & Metabolism".

Common effects of COVID-19 on people with diabetes

An analysis of the data from the province of Wuhan in China showed that patients with diabetes mellitus were disproportionately represented in the group of people who were seriously ill and also in the group of the deceased. The researchers advise that medical teams must be particularly careful and careful when dealing with this group of patients.

What makes diabetics more susceptible to COVID-19?

The data from China indicate that people with endocrinological diseases are exposed to additional risks from COVID-19. According to the researchers, affected people should isolate themselves in order to reduce their risk of infection. There are endocrinological disorders that affect the body's ability to produce steroid hormones (glucocorticoids) to help overcome the infection. This could make some of these people more susceptible to the effects of COVID-19, the research team said.

High doses of glucocorticoids limit the immune system

Patients with known adrenal problems are treated with so-called replacement glucocorticoids. If such people begin to develop symptoms of COVID-19, they should immediately take a double dose of the medication, the research group advises. However, there are many people who take glucocorticoids due to inflammatory diseases. Some of these people take high doses that suppress their immune systems. As a result, the body may not respond appropriately to COVID-19 disease.

How should medical professionals react?

While treatment with glucocorticoids does not in itself play a role in the treatment of COVID-19, medical professionals should consider intravenous stress doses in anyone who has previously been treated with glucocorticoids and whose condition worsens with COVID-19.

Do not stop taking medication yourself!

These recommendations only apply to certain patient groups. People should not come up with the idea of ​​changing the scheme of taking their medication independently. Be sure to talk to your doctor about this topic beforehand. (as)

Author and source information

This text corresponds to the specifications of the medical literature, medical guidelines and current studies and has been checked by medical doctors.


  • Ursula B Kaiser, Raghavendra G Mirmira, Paul M Stewart: Our Response to COVID-19 as Endocrinologists and Diabetologists, in Journal of Clinical Endocrinology & Metabolism (Published 3/31/2020 Volume 105, Issue 5), Journal of Clinical Endocrinology & Metabolism

Video: Diabetes u0026 Cancer Patients at Greater Risk. COVID-19. Dr. PC Manoria (January 2023).